End-of-day quote
Ho Chi Minh S.E.
18:00:00 2024-05-19 EDT
|
5-day change
|
1st Jan Change
|
80,000
VND
|
-1.11%
|
|
+1.27%
|
-10.11%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Capitalization
1 |
2,507,758
|
2,967,859
|
3,780,289
|
3,689,098
|
3,689,098
|
3,316,043
|
Enterprise Value (EV)
1 |
2,507,758
|
2,967,859
|
3,780,289
|
3,689,098
|
3,689,098
|
3,316,043
|
P/E ratio
|
18.5
x
|
17.1
x
|
-
|
-
|
-
|
-
|
Yield
|
-
|
-
|
-
|
-
|
-
|
3.75%
|
Capitalization / Revenue
|
1.46
x
|
-
|
1.74
x
|
1.54
x
|
1.61
x
|
1.3
x
|
EV / Revenue
|
1.46
x
|
-
|
1.74
x
|
1.54
x
|
1.61
x
|
1.3
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
8.12
x
|
6.46
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
2.9
x
|
2.68
x
|
2.1
x
|
Nbr of stocks (in thousands)
|
41,451
|
41,451
|
41,451
|
41,451
|
41,451
|
41,451
|
Reference price
2 |
60,500
|
71,600
|
91,200
|
89,000
|
89,000
|
80,000
|
Announcement Date
|
3/3/20
|
3/25/21
|
1/27/22
|
1/31/23
|
1/30/24
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net sales
1 |
1,716,062
|
-
|
2,176,276
|
2,398,918
|
2,296,644
|
2,555,000
|
EBITDA
1 |
-
|
-
|
-
|
-
|
454,086
|
513,000
|
EBIT
1 |
-
|
-
|
-
|
-
|
359,456
|
410,000
|
Operating Margin
|
-
|
-
|
-
|
-
|
15.65%
|
16.05%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
195,787
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
3,269
|
4,185
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
3,000
|
Announcement Date
|
3/3/20
|
3/25/21
|
1/27/22
|
1/31/23
|
1/30/24
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
22.1%
|
18.8%
|
19.9%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
15.3%
|
14%
|
15.7%
|
Assets
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
1 |
-
|
-
|
-
|
30,667
|
33,204
|
38,076
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/3/20
|
3/25/21
|
1/27/22
|
1/31/23
|
1/30/24
|
-
|
Last Close Price
80,000
VND Average target price
95,300
VND Spread / Average Target +19.12% Consensus |
1st Jan change
|
Capi.
|
---|
| -10.11% | 132M | | +34.35% | 693B | | +29.39% | 584B | | -3.49% | 372B | | +20.15% | 332B | | +6.19% | 294B | | +14.11% | 239B | | -3.03% | 211B | | +10.02% | 210B | | +9.21% | 168B |
Other Pharmaceuticals
|